Brand Highlights Freya Meds is a telehealth-based brand specializing in personalized medical weight loss programs
(48 placebo-controlled RCTs, 94,245 participants
Addiction to alcohol, opioids, and other substances contributes to significant medical, social, and economic burdens
From its initial use in the treatment of type 2 diabetes to its expansion to 12 indications such as obesity, cardiovascular disease, chronic kidney disease, and metabolic dysfunction related fatty liver disease (MASLD), the annual sales of GLP-1 drugs exceeded 100 billion dollars, and its research and development funding reached a historical peak of 21.72 million dollars in 2025
This content is for informational and educational purposes only and does not constitute medical or clinical advice